Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study
Open Access
- 21 June 2006
- journal article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 6 (1) , 4
Abstract
Insulin is the recommend therapeutic agent of choice for the management of Cystic Fibrosis Related Diabetes (CFRD), despite only sub-optimal reductions in glycemic control and increased morbidity and mortality reported by centers using this agent. The newer insulin sensitizing agents demonstrated to have anti-inflammatory mechanisms may provide an alternative management option for CFRD. A prospective case based therapeutic comparison between insulin, sulfonylurea, metformin and thiazolidinedione was observed over one decade with 20 CFRD patients diagnosed using American Diabetes Association guideline standards. Patients entering the study elected treatment based on risk and benefit information provided for treatment options. Patients receiving organ transplant or requiring combination diabetic medications were excluded from the study. No statistical advantage was achieved regarding overall glycemic control for oral agents over insulin. Additional outcome measures including changes in weight, liver function testing and FEV1 were not statistically significant. Insulin alone may not be the only therapeutic option in managing CFRD. Oral hypoglycemic agents were equally effective in treating CFRD and may provide an alternative class of agents for patients reluctant in using insulin.Keywords
This publication has 19 references indexed in Scilit:
- Conventional measures underestimate glycaemia in cystic fibrosis patientsDiabetic Medicine, 2004
- Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapyActa Paediatrica, 2001
- Inhibition by troglitazone of the antigen‐induced production of leukotrienes in immunoglobulin E‐sensitized RBL‐2H3 cellsBritish Journal of Pharmacology, 2000
- Glucose tolerance in patients with cystic fibrosis: five year prospective studyBMJ, 1995
- Insulin Sensitivity in Cystic FibrosisDiabetes, 1994
- Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosisThe Journal of Clinical Endocrinology & Metabolism, 1994
- Glipizide Treatment of Patients with Cystic Fibrosis and Impaired Glucose ToleranceJournal of Pediatric Gastroenterology and Nutrition, 1994
- Management dilemmas in the individual with cystic fibrosis and diabetesJournal of the American Dietetic Association, 1994
- Pancreatic endocrine function in cystic fibrosisThe Journal of Pediatrics, 1991
- The Interaction of 2 DiseasesMedicine, 1986